229 related articles for article (PubMed ID: 34113089)
1. A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease.
Huang WC; Chen CY; Liao WC; Wu BR; Chen WC; Tu CY; Chen CH; Cheng WC
Int J Chron Obstruct Pulmon Dis; 2021; 16():1555-1568. PubMed ID: 34113089
[TBL] [Abstract][Full Text] [Related]
2. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.
Buhl R; Criée CP; Kardos P; Vogelmeier CF; Kostikas K; Lossi NS; Worth H
Int J Chron Obstruct Pulmon Dis; 2018; 13():2557-2568. PubMed ID: 30197512
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
4. When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment.
Cheng WC; Wu BR; Liao WC; Chen CY; Chen WC; Hsia TC; Tu CY; Chen CH; Hsu WH
Int J Chron Obstruct Pulmon Dis; 2020; 15():3375-3384. PubMed ID: 33376318
[TBL] [Abstract][Full Text] [Related]
5. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand.
Xu X; Milea D; Navarro Rojas AA; Braganza A; Holbrook T; Marett B; Young R; Scott RJ; Gribben B
Int J Chron Obstruct Pulmon Dis; 2021; 16():1835-1850. PubMed ID: 34177262
[TBL] [Abstract][Full Text] [Related]
6. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
[TBL] [Abstract][Full Text] [Related]
7. Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study.
Dalon F; Roche N; Belhassen M; Nolin M; Pegliasco H; Deslée G; Housset B; Devillier P; Van Ganse E
Int J Chron Obstruct Pulmon Dis; 2019; 14():1839-1854. PubMed ID: 31692478
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
9. Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study.
Jiang L; Kendzerska T; Aaron SD; Stukel TA; Stanbrook MB; Tan W; Pequeno P; Gershon AS
COPD; 2022; 19(1):315-323. PubMed ID: 35946353
[TBL] [Abstract][Full Text] [Related]
10. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
Suissa S; Dell'Aniello S; Ernst P
Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
[TBL] [Abstract][Full Text] [Related]
11. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic burden of COPD for patients receiving dual or triple therapy.
Chen S; Small M; Lindner L; Xu X
Int J Chron Obstruct Pulmon Dis; 2018; 13():1365-1376. PubMed ID: 29731624
[TBL] [Abstract][Full Text] [Related]
13. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.
Park SY; Kim S; Kim JH; Kim SH; Lee T; Yoon SY; Kim MH; Moon JY; Yang MS; Jung JW; Kim JH; Choi JH; Park CS; Kim S; Lee J; Kwon JW; Hur GY; Kim SH; Kim HK; Shin YS; Kim SH; Nam YH; Jang AS; Park SY; Kim TB;
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1304-1311.e2. PubMed ID: 33184024
[TBL] [Abstract][Full Text] [Related]
15. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review.
Riesco Miranda JA; Calle Rubio M; Díaz Pérez D; López-Campos JL; Trigueros Carrero JA; Celli B
Arch Bronconeumol; 2024 Jan; 60(1):55-58. PubMed ID: 37985278
[No Abstract] [Full Text] [Related]
17. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
18. [Asthma and COPD: guidance in the jungle of inhalative drugs].
Hering T
MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
[No Abstract] [Full Text] [Related]
19. Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.
Langham S; Lewis J; Pooley N; Embleton N; Langham J; Han MK; Chalmers JD
Respir Res; 2019 Nov; 20(1):242. PubMed ID: 31684965
[TBL] [Abstract][Full Text] [Related]
20. Open triple therapy for chronic obstructive pulmonary disease: Patterns of prescription, exacerbations and healthcare costs from a large Italian claims database.
Calabria S; Ronconi G; Dondi L; Piccinni C; Pedrini A; Esposito I; Pistelli R; Martini N
Pulm Pharmacol Ther; 2020 Apr; 61():101904. PubMed ID: 32092473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
